These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 4817870

  • 1. Current status of bilateral adrenalectomy or advanced prostatic carcinoma.
    Bhanalaph T, Varkarakis MJ, Murphy GP.
    Ann Surg; 1974 Jan; 179(1):17-23. PubMed ID: 4817870
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Lung metastases in prostatic carcinoma. Clinical significance.
    Varkarakis MJ, Winterberger AR, Gaeta J, Moore RH, Murphy GP.
    Urology; 1974 Apr; 3(4):447-52. PubMed ID: 4856662
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Adrenalectomy and hypophysectomy in advanced prostatic carcinoma.
    Reynoso G, Murphy GP.
    Cancer; 1972 Apr; 29(4):941-5. PubMed ID: 5017363
    [No Abstract] [Full Text] [Related]

  • 8. [Prognosis and treatment of prostatic carcinoma].
    Klug W.
    Zentralbl Chir; 1968 Mar 09; 93(10):362-6. PubMed ID: 5674208
    [No Abstract] [Full Text] [Related]

  • 9. PROGNOSTICATION OF CARCINOMA OF THE PROSTATE METASTATIC TO THE SKELETON BY RADIOLOGICAL STUDIES.
    SCHIRMER HK, RICHARDS GJ.
    J Urol; 1964 Dec 09; 92():714-20. PubMed ID: 14241206
    [No Abstract] [Full Text] [Related]

  • 10. Adrenalectomy and hypophysectomy for prostatic cancer.
    Brendler H.
    Urology; 1973 Aug 09; 2(2):99-102. PubMed ID: 4358703
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Hypophysectomy for disseminated prostatic carcinoma.
    Murphy GP, Boctor ZN, Gailani S, Belmusto L.
    J Surg Oncol; 1969 Aug 09; 1(1):81-95. PubMed ID: 4107045
    [No Abstract] [Full Text] [Related]

  • 13. Management of reactivated prostatic cancer.
    Murphy G.
    Vitam Horm; 1975 Aug 09; 33():399-415. PubMed ID: 779252
    [No Abstract] [Full Text] [Related]

  • 14. Carcinoma of prostate. Long-term survival after bilateral adrenalectomy.
    Merrin C, Murphy GP, Chu TM, Mittleman A.
    Urology; 1974 Feb 09; 3(2):223-5. PubMed ID: 4812670
    [No Abstract] [Full Text] [Related]

  • 15. The effect of cyproterone acetate on advanced carcinoma of the prostate.
    Geller J, Vazakas G, Fruchtman B, Newman H, Nakao K, Loh A.
    Surg Gynecol Obstet; 1968 Oct 09; 127(4):748-58. PubMed ID: 5675191
    [No Abstract] [Full Text] [Related]

  • 16. [Rate of survival in prostatic cancer with bone metastasis].
    Kuntz D, Ryckewaert A.
    Rev Fr Etud Clin Biol; 1969 Oct 09; 14(6):609-13. PubMed ID: 5824263
    [No Abstract] [Full Text] [Related]

  • 17. [Prostatic cancer: indications for hormone therapy].
    Bruntsch U, Gallmeier WM.
    MMW Munch Med Wochenschr; 1979 Mar 02; 121(9):300-2. PubMed ID: 85258
    [No Abstract] [Full Text] [Related]

  • 18. Cyproterone acetate in the treatment of advanced carcinoma of the prostate.
    Smith RB, Walsh PC, Goodwin WE.
    J Urol; 1973 Jul 02; 110(1):106-8. PubMed ID: 4713345
    [No Abstract] [Full Text] [Related]

  • 19. Response of men with advanced prostatic carcinoma to exogenous administration of testosterone.
    Prout GR, Brewer WR.
    Cancer; 1967 Nov 02; 20(11):1871-8. PubMed ID: 4168724
    [No Abstract] [Full Text] [Related]

  • 20. The use of radioactive phosphorus to treat bone pain in metastatic carcinoma of the prostate.
    Morales A, Burr RC, Bruce AW.
    Can Med Assoc J; 1970 Aug 15; 103(4):372-3. PubMed ID: 5447717
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.